PERSPECTA

News from every angle

← Back to headlines

Financial implications of Lisraya's pricing for Roivant

Analysis of how the $35,000 monthly price tag for Lisraya could impact the pharmaceutical company Roivant Sciences.

8 Sept, 00:27 — 8 Sept, 00:27
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual1d ago

What Lisraya’s $35,000 Monthly Price Could Mean for Roivant (ROIV)

Read full article →

Related Stories

Scientists Warn Very Hot Drinks May Increase Esophageal Cancer Risk

1h ago

Greek Artist Giorgos Mazonakis Dies After Hospital Struggle

3h ago

Bangladesh Measles Outbreak Kills Over 1,000 Children

4h ago

Greek Woman Gives Birth from Embryo Frozen for 22 Years

4h ago

Financial implications of Lisraya's pricing for Roivant | Perspecta News